Neurotech Pharmaceuticals
Latest round
- Series F
Last raised
- Apr 2014
Total raised
- $40M
Investors
- 13
About Neurotech Pharmaceuticals
Neurotech Pharmaceuticals, Inc.Neurotech Pharmaceuticals, Inc. specializes in developing therapies for chronic eye diseases. The company is headquartered in Lincolnshire, US. Rich Small serves as the CEO.05 million.Neurotech Pharmaceuticals, Inc. specializes in the development of innovative therapies aimed at addressing chronic eye diseases, primarily through its Encapsulated Cell Therapy (ECT) platform. The core offering of the company is its ECT, designed to release Ciliary Neurotrophic Factor (CNTF), which protects retinal photoreceptors from degeneration. This therapy targets Macular Telangiectasia (MacTel) Type 2, a condition that progressively diminishes central vision. Neurotech aims to enhance the quality of life for patients with MacTel by providing effective treatment options.Neurotech Pharmaceuticals generates revenue through partnerships with healthcare institutions and potential direct sales of its therapies to medical providers. The company engages in business-to-business transactions, collaborating with clinics and hospitals to facilitate the distribution of its Encapsulated Cell Therapy products. The company is expected to continue designing therapies that enhance treatment for chronic eye diseases. While specific new products and their release dates have not been disclosed, the firm aims to explore expansion into new geographic regions, including additional markets within Europe and North America, by the end of 2015.
Who invested in Neurotech Pharmaceuticals
13 investors across 2 rounds
See all investors in Neurotech Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Neurotech Pharmaceuticals
Who invested in Neurotech Pharmaceuticals?
Neurotech Pharmaceuticals has 13 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Neurotech Pharmaceuticals raised?
Neurotech Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Neurotech Pharmaceuticals last raise money?
Neurotech Pharmaceuticals's most recent round on record is a Series F, in Apr 2014.
What does Neurotech Pharmaceuticals do?
Neurotech Pharmaceuticals, Inc.
Where is Neurotech Pharmaceuticals headquartered?
Neurotech Pharmaceuticals is headquartered in Lincolnshire, US.
Which VCs invest in companies like Neurotech Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Neurotech Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series F
Raising like Neurotech Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.